 dehydroepiandrosteron dehydroxycorticosteroid plasm stage breast cancer mastopathi depress dehydroepiandrosteron plasma corticosteroid averag shorten advanc breast cancer stage iv lowest corticosteroid valu three group patient 6 hour infus dehydroepiandrosteron phosphat dehydroepiandrosteron provabl 12 hour group suffer mastopathi breast cancer group stage iv time reach level initi valu breast cancer group stage iv time reach level initi valu breast cancer group stage ii behav intermedi last dehydroepiandrosteron attribut acceler transform advanc breast cancer 